LivWell, founded in 2020, specializes in treating patients with chronic conditions, providing services for those with gastroenterology, ophthalmology, oncology, cardiology, immunology, neurology and rheumatology problems.
The investment amount was undisclosed, but LivWell said it plans to use the funds to accelerate national growth.
LivWell operates ambulatory infusion centers in Arizona, California, New Mexico, Indiana and Pennsylvania.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.